Recombinant von Willebrand Factor (vonicog alfa) reduces platelet inhibition caused by antiplatelet drugs and has potential as an acute haemostatic agent

Desborough, M. J. R., Mitchell, J. L., Whitworth, P., Al Juwaiser, A., Sage, T., Kriek, N., Little, G., Vaiyapuri, S. ORCID: https://orcid.org/0000-0002-6006-6517, Gibbins, J. M. ORCID: https://orcid.org/0000-0002-0372-5352 and Bye, A. P. ORCID: https://orcid.org/0000-0002-2061-2253 (2026) Recombinant von Willebrand Factor (vonicog alfa) reduces platelet inhibition caused by antiplatelet drugs and has potential as an acute haemostatic agent. Haematologica. ISSN 0390-6078 doi: 10.3324/haematol.2025.289179 (In Press)